Track topics on Twitter Track topics that are important to you
ENGLEWOOD, Colo., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), today announced that Dr. Patrick Gruber, Gevo's Chief Executive Officer, will present at the Jefferies 2015 Industrials Conference on Monday, August 10 at 11:20 a.m. EDT in New York.
To view the webcast, please follow the link: http://wsw.com/webcast/jeff90/gevo. The presentation will also be available for 90 days on the investor relations section of the Gevo website.
For more information on the conference or to schedule a one-on-one meeting with management, please contact your Jefferies representative.
Gevo is a leading renewable technology, chemical products, and next generation biofuels company. Gevo has developed proprietary technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to produce isobutanol, as well as related products from renewable feedstocks. Gevo's strategy is to commercialize biobased alternatives to petroleum-based products to allow for the optimization of fermentation facilities' assets, with the ultimate goal of maximizing cash flows from the operation of those assets. Gevo produces isobutanol, ethanol and high-value animal feed at its fermentation plant in Luverne, MN. Gevo has also developed technology to produce hydrocarbon products from renewable alcohols. Gevo currently operates a biorefinery in Silsbee, TX, in collaboration with South Hampton Resources Inc., to produce renewable jet fuel, octane, and ingredients for plastics like polyester. Gevo has a marquee list of partners including The Coca-Cola Company, Toray Industries Inc. and Total SA, among others. Gevo is committed to a sustainable bio-based economy that meets society's needs for plentiful food and clean air and water.
CONTACT: Media Contacts: David Rodewald/Karen Freedman The David James Agency, LLC +1 805-494-9508 email@example.com Investor Contact: Mike Willis, CFO Gevo, Inc. +1 720-267-8636 firstname.lastname@example.orgNEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...